InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: fred198484 post# 30394

Monday, 10/09/2017 4:27:43 PM

Monday, October 09, 2017 4:27:43 PM

Post# of 38634
Hal/hap studies I read are not that much costly, but yes, even if they are way below a pIII phase cost they still require money.

The suicidal definition is dependent on who would be the eventual new shares buyer, hedge fund or pharma co.?

What I am saying is that they don't need 15mln tomorrow, and if they want they could go several other routes to raise money.

So,it all depends on Odidi's willingness to step down, not only as a CEO.

Finally, they should give out something very good on Q3 to have the shares jump and then raise, otherwise they have to raise below 1.00 which will for sure be very dumb

All jmho